Recurrent group A <i>Streptococcus</i> tonsillitis is an immunosusceptibility disease involving antibody deficiency and aberrant T<sub>FH</sub> cells.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 30728285.
- Also identified by DOI 10.1126/scitranslmed.aau3776 and PMC identifier 6561727.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
"Strep throat" is highly prevalent among children, yet it is unknown why only some children develop recurrent tonsillitis (RT), a common indication for tonsillectomy. To gain insights into this classic childhood disease, we performed phenotypic, genotypic, and functional studies on pediatric group A <i>Streptococcus</i> (GAS) RT and non-RT tonsils from two independent cohorts. GAS RT tonsils had smaller germinal centers, with an underrepresentation of GAS-specific CD4<sup>+</sup> germinal center T follicular helper (GC-T<sub>FH</sub>) cells. RT children exhibited reduced antibody responses to an important GAS virulence factor, streptococcal pyrogenic exotoxin A (SpeA). Risk and protective human leukocyte antigen (HLA) class II alleles for RT were identified. Lastly, SpeA induced granzyme B production in GC-T<sub>FH</sub> cells from RT tonsils with the capacity to kill B cells and the potential to hobble the germinal center response. These observations suggest that RT is a multifactorial disease and that contributors to RT susceptibility include HLA class II differences, aberrant SpeA-activated GC-T<sub>FH</sub> cells, and lower SpeA antibody titers.
Medical subject headings
- Antibodies, Bacterial
- Streptococcus
- Tonsillitis